Zedira

4 articles about Zedira

• 

  Takeda Adds Potential First-in-Class Celiac Treatment to Repertoire

  10/20/2022

  Takeda, Zedira and Dr. Falk Pharma will collaborate to develop ZED1227/TAK-227, a potential first-in-class investigational therapy for the treatment of celiac disease, Takeda announced Thursday.

• Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy

  10/20/2022

  Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy.

• Cooperation Between Zedira And Cardiff University - Transglutaminase 6 Is The Focus Of New Research Into Ataxia

  9/22/2015

• Dr. Falk Pharma And Zedira Enter Phase I Clinical Trials For A Celiac Disease Drug

  3/13/2015